Viral dosing of influenza A infection reveals involvement of RIPK3 and FADD, but not MLKL
Abstract RIPK3 was reported to play an important role in the protection against influenza A virus (IAV) in vivo.Here we show that the requirement of RIPK3 for protection against IAV infection in vivo is only apparent within a limited dose range of IAV challenge.We found that this protective outcome is independent from RIPK3 kinase activity and from